Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia

Circulation

Volumn 96, Issue 6, 1997, Pages 1930-1936

  Mathew, Verghese ^a   Cannan, Charles R ^a   Miller, Virginia M ^a   Barber, Dustan A ^a   Hasdai, David ^a   Schwartz, Robert S ^a   Holmes Jr , David R ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

Circulation; Endothelin; Endothelium derived factors; Hypercholesterolemia

Indexed keywords

ENDOTHELIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BINDING AFFINITY; HYPERCHOLESTEROLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOMOTOR REFLEX;

EID: 0030823394     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1930     Document Type: Article

References (40)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
3. Lerman A, Hildebrand FL Jr, Margulies KB, O'Murchu B, Perrella MA, Heublein DM, Schwab TR, Burnett JC Jr. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc. 1990;65:1441-1455.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and acute coronary syndromes (Part I). N Engl J Med. 1992;326:242-250.
5. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau V. Impaired vasodilation of forearm vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
6. Zeiher AM, Drexler H, Wollschager H, Just H. Modulation of vasomotor tone in humans: progressive endothelial dysfunction with different early stages of atherosclerosis. Circulation. 1991;83:391-401.
7. Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, Fuster V, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 1993;88:2923-2928.
8. Cannan CR, Burnett JC Jr, Brandt RR, Lerman A. Endothelin at pathophysiologic concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 1995;92: 3312-3317.
9. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary flow velocity. Circulation. 1992;85:1899-1911.
10. Bove AA, Holmes DR Jr, Owen RM, Bresnahan JF, Reeder GS, Smith HC, Vlietstra RE. Estimation of the effects of angioplasty on coronary stenosis using quantitative video angiography. Cath Cardiovasc Diagn. 1985;11:5-16.
11. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol. 1993;71:3D-9D.
12. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
13. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation. 1992;85:1894-1898.
14. Mathew V, Hasdai D, Lerman A. The role of endothelin in coronary atherosclerosis. Mayo Clin Proc. 1996;71:769-777.
15. Horio T, Kohno M, Murakawa K, Yasunari K, Yokokawa K, Ueda M, Takeda T. Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats. Atherosclerosis. 1991; 89:239-246.
16. Haak T, Marz W, Jungmann E, Hausser S, Siekmeier R, Gross W, Usadel KH. Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Invest. 1994;72:580-584.
17. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70:1191-1197.
18. Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchart JC. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett. 1991;293:127-130.
19. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
20. Merkel LA, Bilder GE. Modulation of vascular reactivity by vasoactive peptides in aortic rings from hypercholesterolemic rats. Eur J Pharmacol. 1992;222:175-179.
21. Elshourbagy NA, Korman DR, Wu H-s, Sylvester DR, Lee JA, Nuthalaganti P, Bergsma DJ, Kumar CS, Nambi P. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem. 1993;268:3873-3879.
22. Dagassan PH, Breu V, Clozel M, Kunzli A, Vogt P, Turina M, Kioski W, Clozel JP. Up-regulation of endothelin-B receptor in atherosclerotic human arteries. J Cardiovasc Pharmacol. 1996;27:147-153.
23. Elshourbagy NA, Korman DR, Wu HL, Sylvester DR, Lee JA, Nuthalaganti P, Bergsma DJ, Kumar CS, Nambi P. Molecular characterization of the human endothelin receptors. J Biol Chem. 1993;268:3873-3879.
24. Calderone A, Rouleau JL, de Champlain J, Belichard P, Stewart DJ. Regulation of the endothelin-1 transmembrane signalling pathway: the potential role of agonist induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure. J Mol Cell Cardiol. 1993;25:895-903.
25. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension. 1996;27:49-55.
26. Flowers MA, Wang Y, Stewart RJ, Patel B, Marsden PA. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am J Physiol. 1995;269:H1988-H1997.
27. Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP. Patients with evidence of coronary endothelial function as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992;85:1390-1397.
28. Dohi Y, Hahn AW, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992;19:131-137.
29. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
30. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 1990;336:897-900.
31. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
32. Smith REA, Palmer RMJ, Bucknall CA, Moncada S. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res. 1992;26:508-512.
33. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau V, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;99:1248-1253.
34. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;228:1546-1550.
35. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
36. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
37. Tanner FC, Noll G, Boulanger CM, Luscher TF. Oxidized low density lipoproteins inhibit relaxation of porcine coronary arteries. Circulation. 1991;83:2012-2020.
38. Galle J, Mulsch, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 1991;11:198-203.
39. Fogliatto G, Musanti R, Pirillo A, Ghiselli G. Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line. J Cardiovasc Risk. 1995;2:123-130.
40. Beck KF, Mohaupt MG, Sterzel RB. Endothelin-1 inhibits cytokine-stimulated transcription of inducible nitric oxide synthase in glomerular mesangial cells. Kidney Int. 1995;48:1893-1899.